Transthyretin Amyloidosis ATTR Market

hat ein neuen Blog hinzugefügt Health

2026-08-31 07:34:29 - Übersetzen -

Transthyretin Amyloidosis ATTR Market – Earlier Diagnosis Expands Rare Disease Treatment Access

The transthyretin amyloidosis, or ATTR, market is growing as awareness improves, diagnostic technologies advance, and new targeted therapies become available. The market was valued at USD 2.82 billion in 2024 and is projected to reach USD 5.8 billion by 2032, growing at a CAGR of 9.42%. 1177 ATTR amyloidosis is a rare, progressive condition caused by misfolded transthyretin protein that forms...

0 Kommentare 0 Geteilt 133 Ansichten 0 Bewertungen